Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

IMI
Symposium

S01--Fungal Infections in CF

Thursday, September 26, 2024
2:30 PM – 4:30 PM ET
Location:104 AB

Recorded Session

Over the past several decades, significant advancements in cystic fibrosis (CF) treatment have greatly enhanced the quality of life for people with CF. However, fungal infections in the lungs remain a persistent and challenging complication. This symposium will explore the current landscape of fungal infections in CF, highlighting the latest clinical research and how these infections are evolving in the context of highly effective modulators. We will also address emerging challenges and focus on the development of new therapeutics aimed at improving the diagnosis, treatment, and overall management of fungal infections in CF, with the ultimate goal of enhancing the lives of all individuals affected by the disease.

Learning Objectives:

  • Explain how fungal infections in cystic fibrosis (CF) are evolving in the era of CFTR modulators.
  • Understand the shifting strategies in managing fungal infections and explore clinical trials focused on new treatments.
  • Identify the beneficial and adverse effects of antifungal treatments in CF care.

Presentations:

  • 2:30 PM – 4:30 PM ET
    S01.2- Effects of ETI on Aspergillus

    Speaker: Jane Jones, PhD (she/her/hers) – Dartmouth College

  • 2:30 PM – 4:30 PM ET
    S01.3- Immune Responses to Fungal Infections in CF

    Speaker: Carsten Schwarz, MD (he/him/his) – HMU-Health and Medical University Potsdam, Clinic Westbrandenburg, Division Cystic Fibrosis, Potsdam, Germany

  • 2:30 PM – 4:30 PM ET
    S01.4- Considerations for Antifungal Treatment in CF: Pharmacist Perspective

    Speaker: Lauren  C. Magee , PharmD, BCPS (she/her/hers) – Virginia Commonwealth University Health System

  • 2:30 PM – 4:30 PM ET
    S01.5- Considerations for Antifungal Treatment in CF: Clinician Perspective

    Speaker: Imogen Felton, PhD MRCP (she/her/hers) – Royal Brompton Hospital